Etiology and Treatment of Urolithiasis

American Journal of Kidney Diseases

Volumn 18, Issue 6, 1991, Pages 624-637

  Pak, Charles Y C ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

hypercalciuria; hypocitraturia; Nephrolithiasis

Indexed keywords

ACETOHYDROXAMIC ACID; ALLOPURINOL; AMMONIA; CALCIUM OXALATE; CALCIUM PHOSPHATE; CELLULOSE PHOSPHATE; CITRATE CALCIUM; CITRATE POTASSIUM; CYSTINE; GLUCONATE MAGNESIUM; MAGNESIUM; PENICILLAMINE; PHOSPHATE; THIAZIDE DIURETIC AGENT; TIOPRONIN; UNCLASSIFIED DRUG; URIC ACID;

CYSTINURIA; HUMAN; NEPHROLITHIASIS; REVIEW;

EID: 0026318109     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(12)80602-0     Document Type: Article

References (51)

1. Similarity of urinary risk factors among stone-forming patients in five regions of the United States
2. Extracorporeally induced destruction of kidney stones by shock waves
3. Medical management of nephrolithiasis in Dallas: Update 1987
4. Composition and structure of urinary stone
5. Successful management of uric acid nephrolithiasis with potassium citrate
6. Prevention of infected urinary stones by urease inhibition
7. Modulation by calcium of the inhibitor activity of citrate, chondroitin sulfate and urinary glycoprotein against calcium oxalate crystallization
8. Pathogenesis of hypercalciuria
9. The hypercalciurias. Causes, parathyroid functions and diagnostic criteria
10. The role of 1 a,25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria
11. A critical evaluation of the role of phosphate in the pathogenesis of absorptive hypercalciuria
12. Pathogenetic role of 1 a,25-dihydroxyvitamin D in sarcoidosis and absorptive hypercalciuria. Different response to prednisolone therapy
13. Familial idiopathic hypercalciuria
14. Intestinal absorption of calcium, magnesium, phosphate and oxalate: Deviation from normal in idiopathic urolithiasis
15. Evidence for secondary hyperparathyroidism in idiopathic hypercalciuria
16. Physiological basis for absorptive and renal hypercalciurias
17. Selective effects of thiazide therapy on serum 1 a,25-dihydroxyvitamin D and intestinal calcium absorption in renal and absorptive hypercalciurias
18. The importance of circulating 1,25-dihydroxyvitamin D in the pathogenesis of hypercalciuria and renal-stone formation in primary hyperparathyroidism
19. 3 in primary hyperparathyroidism
20. A lack of unique pathophysiologic background for nephrolithiasis of primary hyperparathyroidism
21. Increased monocyte interleukin-1 activity and decreased vertebral bone density in patients with fasting idiopathic hypercalciuria
22. Elevated production rate of 1,25-dihydroxyvitamin D in patients with absorptive hypercalciuria
23. 2vitamin D levels in humans. Studies in healthy subjects, in calcium-stone formers and in patients with primary hyperparathyroidism
24. 3 levels in patients with idiopathic hypercalciuria and in normal subjects
25. The influence of renal prostaglandins on urinary calcium excretion in idiopathic urolithiasis
26. Citrate and renal calculi
27. Transport of citrate across renal brush border membrane: effects of dietary acid and alkali loading
28. Hypocitraturia in patients with gastrointestinal malabsorption
29. Diminished urinary excretion of citrate during deficiencies of potassium in man
30. Relationship role of animal protein-rich diet to kidney stone formation and calcium metabolism
31. Chemical factors important to calcium nephrolithiasis. Evidence for impaired hydroxycarboxylic acid absorption causing hyperoxaluria
32. Uric acid and calcium oxalate nephrolithiasis
33. Hyperuricosuric calcium oxalate nephrolithiasis
34. Mechanism for calcium urolithiasis among patients with hyperuricosuria. Supersaturation of urine with respect to monosodium urate
35. Acquired hyperoxaluria, nephrolithiasis and intestinal disease. Description of a syndrome
36. Enteric hyperoxaluria and other hyperoxaluric states
37. A simple test for the diagnosis of absorptive, resorptive and renal hypercalciurias
38. Ambulatory evaluation of nephrolithiasis. Classification, clinical presentation and diagnostic criteria
39. A detailed evaluation of oral phosphate therapy in selected patients with primary hyperparathyroidism
40. Ethinyl estradiol and norethindrone in the treatment of primary hyperparathyroidism in postmenopausal women
41. A cautious use of sodium cellulose phosphate in the management of calcium nephrolithiasis
42. Correction of hypocitraturia and prevention of stone formation by combined thiazide and potassium citrate therapy in thiazide-unresponsive hypercalciuric nephrolithiasis
43. Triamterene nephrolithiasis
44. Effect of amiloride with or without hydrochlorothiazide on urinary calcium and saturation of calcium salts
45. Orthophosphate therapy decreases urinary calcium excretion and serum 1,25-dihydroxyvitamin D concentrations in idiopathic hypercalciuria
46. Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis
47. Hypercalciuria and altered intestinal calcium absorption occurring independently of vitamin D in incomplete distal renal tubular acidosis
48. Idiopathic hypocitraturic calcium oxalate nephrolithiasis successfully treated with potassium citrate
49. Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone-forming salt
50. Management of cystine nephrolithiasis with alpha-mercaptopropionylglycine (Thiola)
51. Struvite stones